Page last updated: 2024-08-25

squalamine and Neoplasms

squalamine has been researched along with Neoplasms in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (20.00)	18.2507
2000's	4 (80.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Eckhardt, SG; Goetz, AD; Hammond, LA; Hao, D; Holroyd, KJ; Mamun, K; McCreery, HA; Patnaik, A; Rowinsky, EK; Schwartz, GH; Takimoto, CH; Tolcher, AW; Williams, JI	1
Parker, L	1
Chen, Q; Gonzalez, CM; Holroyd, KJ; Jundt, CH; Marty, J; Mclane, MP; Stringer, SD; Von Hoff, DD; Weitman, S; Williams, JI; Zasloff, M	1
Marwick, C	1
Bhargava, P; Dahut, W; Hait, H; Hawkins, MJ; Holroyd, KJ; Marshall, JL; Rizvi, N; Song, S; Trocky, N; Williams, JI	1

Trials

2 trial(s) available for squalamine and Neoplasms

Article	Year
A Phase I and pharmacokinetic study of squalamine, an aminosterol angiogenesis inhibitor. Clinical cancer research : an official journal of the American Association for Cancer Research, 2003, Volume: 9, Issue:7 Topics: Adolescent; Adult; Angiogenesis Inhibitors; Area Under Curve; Cholestanols; Dose-Response Relationship, Drug; Female; Humans; Liver; Male; Middle Aged; Models, Chemical; Neoplasms; Sterols; Time Factors	2003
A phase I and pharmacokinetic study of squalamine, a novel antiangiogenic agent, in patients with advanced cancers. Clinical cancer research : an official journal of the American Association for Cancer Research, 2001, Volume: 7, Issue:12 Topics: Adult; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Anticarcinogenic Agents; Cholestanols; Dose-Response Relationship, Drug; Fatigue; Female; Humans; Liver; Male; Metabolic Clearance Rate; Middle Aged; Neoplasms	2001

Article

Year

A Phase I and pharmacokinetic study of squalamine, an aminosterol angiogenesis inhibitor.

Clinical cancer research : an official journal of the American Association for Cancer Research, 2003, Volume: 9, Issue:7

Topics: Adolescent; Adult; Angiogenesis Inhibitors; Area Under Curve; Cholestanols; Dose-Response Relationship, Drug; Female; Humans; Liver; Male; Middle Aged; Models, Chemical; Neoplasms; Sterols; Time Factors

2003

A phase I and pharmacokinetic study of squalamine, a novel antiangiogenic agent, in patients with advanced cancers.

Clinical cancer research : an official journal of the American Association for Cancer Research, 2001, Volume: 7, Issue:12

Topics: Adult; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Anticarcinogenic Agents; Cholestanols; Dose-Response Relationship, Drug; Fatigue; Female; Humans; Liver; Male; Metabolic Clearance Rate; Middle Aged; Neoplasms

2001

Other Studies

3 other study(ies) available for squalamine and Neoplasms

Article	Year
Paediatric oncologists look forward to the millennium. Lancet (London, England), 1999, Sep-25, Volume: 354, Issue:9184 Topics: Anticarcinogenic Agents; Child; Cholestanols; Humans; Medical Oncology; Neoplasms; Pediatrics	1999
Squalamine treatment of human tumors in nu/nu mice enhances platinum-based chemotherapies. Clinical cancer research : an official journal of the American Association for Cancer Research, 2001, Volume: 7, Issue:3 Topics: Actins; Animals; Anticarcinogenic Agents; Antigens, CD; Antineoplastic Agents; Cadherins; Carcinoma, Non-Small-Cell Lung; Cell Adhesion; Cells, Cultured; Cholestanols; Cisplatin; Endothelium, Vascular; Humans; Immunohistochemistry; Lung Neoplasms; Mice; Mice, Nude; Neoplasm Transplantation; Neoplasms; Platinum Compounds; Time Factors; Tumor Cells, Cultured; Umbilical Veins	2001
Natural compounds show antiangiogenic activity. Journal of the National Cancer Institute, 2001, Nov-21, Volume: 93, Issue:22 Topics: Angiogenesis Inhibitors; Antineoplastic Agents; Cholestanols; Clinical Trials as Topic; Female; Humans; Male; Neoplasms; Neovascularization, Pathologic; Tissue Extracts	2001